rosiglitazone has been researched along with Bone Diseases, Metabolic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calzone, R; Cugno, C; Halade, GV; Kizhakayil, D; Rahman, MM; Rahman, SM | 1 |
1 other study(ies) available for rosiglitazone and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Omega-3 fatty acid-rich fish oil supplementation prevents rosiglitazone-induced osteopenia in aging C57BL/6 mice and in vitro studies.
Topics: Adipogenesis; Aging; Animals; Bone Diseases, Metabolic; Cell Differentiation; Diabetes Mellitus, Type 2; Dietary Supplements; Disease Models, Animal; Fatty Acids, Omega-3; Female; Humans; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Osteoblasts; Osteoclasts; Osteogenesis; Primary Cell Culture; RAW 264.7 Cells; Rosiglitazone | 2021 |